Global Lung Cancer Genomic Testing Medicine Market to Grow at a CAGR of 10.1% during Forecast Period
Global lung cancer genomic testing medicine market is growing at a high CAGR because of the rising number of cancer patients, which has led to the advent of novel tests. In lung cancer research, pharmacogenomics and companion diagnostics have been emphasized.

